Baidu
map

神经外科指南

订阅

MedSci主页 / 所有栏目 / 神经外科指南

2018 循证共识指南：儿童外伤性颅脑损伤后交流和吞咽障碍的管理

2018-01-30 国外神经外科相关专家小组（统称） J Head Trauma Rehabil. 2018 Jan 30.

儿童外伤性颅脑损伤交流障碍吞咽障碍

本文共提出了30条建议，包括5条循证建议进而25条共识建议，以指导颅脑损伤后言语，语言进而吞咽障碍的管理。

中文标题：

2018 循证共识指南：儿童外伤性颅脑损伤后交流和吞咽障碍的管理

英文标题：

Evidence- and Consensus-Based Guidelines for the Management of Communication and Swallowing Disorders Following Pediatric Traumatic Brain Injury.

发布机构：

国外神经外科相关专家小组（统称）

发布日期：

2018-01-30

简要介绍：

本文共提出了30条建议，包括5条循证建议进而25条共识建议，以指导颅脑损伤后言语，语言进而吞咽障碍的管理。

 

拓展指南：与颅脑损伤相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2018 循证共识指南：儿童外伤性颅脑损伤后交流和吞咽障碍的管理)] GetToolGuiderByIdResponse(projectId=1, id=67f121c0015515b5, title=2018 循证共识指南：儿童外伤性颅脑损伤后交流和吞咽障碍的管理, enTitle=Evidence- and Consensus-Based Guidelines for the Management of Communication and Swallowing Disorders Following Pediatric Traumatic Brain Injury., guiderFrom=J Head Trauma Rehabil. 2018 Jan 30., authorId=null, author=, summary=本文共提出了30条建议，包括5条循证建议进而25条共识建议，以指导颅脑损伤后言语，语言进而吞咽障碍的管理。 , cover=, journalId=null, articlesId=null, associationId=1328, associationName=国外神经外科相关专家小组（统称）, associationIntro=, copyright=0, guiderPublishedTime=Tue Jan 30 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<P>本文共提出了30条建议，包括5条循证建议进而25条共识建议，以指导颅脑损伤后言语，语言进而吞咽障碍的管理。 </P> <P> </P>拓展指南：<strong>与<font color=red>颅脑损伤</font>相关指南：</strong><br><ul><li><a href="//m.sandwebs.com/guideline/show_article.do?id=0bf041c00155059e" title="美国第四版《重型颅脑损伤救治指南》解读" target=_blank>美国第四版《重型颅脑损伤救治指南》解读</a></li> <li><a href="//m.sandwebs.com/guideline/show_article.do?id=8ef0e1c001a92e37" title="德国成人颅脑损伤治疗指南" target=_blank>德国成人颅脑损伤治疗指南</a></li> <li><a href="//m.sandwebs.com/guideline/show_article.do?id=281d31c00128866a" title="2016 严重创伤性颅脑损伤的管理指南（第4版）[全文]" target=_blank>2016 严重创伤性颅脑损伤的管理指南（第4版）[全文]</a></li> <li><a href="//m.sandwebs.com/guideline/show_article.do?id=b44a31c001288534" title="2016 严重创伤性颅脑损伤的管理指南（第4版）" target=_blank>2016 严重创伤性颅脑损伤的管理指南（第4版）</a></li> <li><a href="//m.sandwebs.com/guideline/show_article.do?id=15d981c0008866d7" title="2012 婴儿、儿童及青少年严重创伤性颅脑损伤急性期治疗指南(第二版)" target=_blank>2012 婴儿、儿童及青少年严重创伤性颅脑损伤急性期治疗指南(第二版)</a></li> 更多信息请点击：<a href="//m.sandwebs.com/guideline/list.do?q=%E9%A2%85%E8%84%91%E6%8D%9F%E4%BC%A4" target=_blank>有关颅脑损伤更多指南</a></ul>, tagList=[TagDto(tagId=69520, tagName=儿童外伤性颅脑损伤), TagDto(tagId=69521, tagName=交流障碍), TagDto(tagId=1464, tagName=吞咽障碍)], categoryList=[CategoryDto(categoryId=25, categoryName=神经外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6061, appHits=142, showAppHits=0, pcHits=4394, showPcHits=1989, likes=144, shares=8, comments=11, approvalStatus=1, publishedTime=Sun Feb 04 10:23:28 CST 2018, publishedTimeString=2018-01-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sun Feb 04 10:23:28 CST 2018, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 14:02:03 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 循证共识指南：儿童外伤性颅脑损伤后交流和吞咽障碍的管理)])
2018 循证共识指南：儿童外伤性颅脑损伤后交流和吞咽障碍的管理
下载请点击：
评论区 (10)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=285274, encodeId=cea22852e4e5, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Feb 05 07:39:18 CST 2018, time=2018-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=285273, encodeId=51dc2852e337, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Feb 05 07:39:12 CST 2018, time=2018-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=285271, encodeId=2cd12852e144, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Feb 05 07:39:05 CST 2018, time=2018-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=285270, encodeId=af792852e028, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Feb 05 07:38:59 CST 2018, time=2018-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=285269, encodeId=408b28526986, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Feb 05 07:38:52 CST 2018, time=2018-02-05, status=1, ipAttribution=)]
    2018-02-05 Y—xianghai

    学习了新知识

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=285274, encodeId=cea22852e4e5, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Feb 05 07:39:18 CST 2018, time=2018-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=285273, encodeId=51dc2852e337, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Feb 05 07:39:12 CST 2018, time=2018-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=285271, encodeId=2cd12852e144, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Feb 05 07:39:05 CST 2018, time=2018-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=285270, encodeId=af792852e028, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Feb 05 07:38:59 CST 2018, time=2018-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=285269, encodeId=408b28526986, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Feb 05 07:38:52 CST 2018, time=2018-02-05, status=1, ipAttribution=)]
    2018-02-05 Y—xianghai

    学习了新知识

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=285274, encodeId=cea22852e4e5, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Feb 05 07:39:18 CST 2018, time=2018-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=285273, encodeId=51dc2852e337, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Feb 05 07:39:12 CST 2018, time=2018-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=285271, encodeId=2cd12852e144, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Feb 05 07:39:05 CST 2018, time=2018-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=285270, encodeId=af792852e028, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Feb 05 07:38:59 CST 2018, time=2018-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=285269, encodeId=408b28526986, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Feb 05 07:38:52 CST 2018, time=2018-02-05, status=1, ipAttribution=)]
    2018-02-05 Y—xianghai

    学习了新知识

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=285274, encodeId=cea22852e4e5, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Feb 05 07:39:18 CST 2018, time=2018-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=285273, encodeId=51dc2852e337, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Feb 05 07:39:12 CST 2018, time=2018-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=285271, encodeId=2cd12852e144, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Feb 05 07:39:05 CST 2018, time=2018-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=285270, encodeId=af792852e028, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Feb 05 07:38:59 CST 2018, time=2018-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=285269, encodeId=408b28526986, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Feb 05 07:38:52 CST 2018, time=2018-02-05, status=1, ipAttribution=)]
    2018-02-05 Y—xianghai

    学习了新知识

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=285274, encodeId=cea22852e4e5, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Feb 05 07:39:18 CST 2018, time=2018-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=285273, encodeId=51dc2852e337, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Feb 05 07:39:12 CST 2018, time=2018-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=285271, encodeId=2cd12852e144, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Feb 05 07:39:05 CST 2018, time=2018-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=285270, encodeId=af792852e028, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Feb 05 07:38:59 CST 2018, time=2018-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=285269, encodeId=408b28526986, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Feb 05 07:38:52 CST 2018, time=2018-02-05, status=1, ipAttribution=)]
    2018-02-05 Y—xianghai

    学习了新知识

    0

以上为热门评论，梅斯医学App还有更多内容
Baidu
map
Baidu
map
Baidu
map